CURE Connections®
Please check back later for more content.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Patients Treated With REGENXBIO’s DMD Gene Therapy RGX-202 Exceed Expected Disease Trajectory on NSAA
2
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1
3
Phase 3 VALOR Data Further Supports Tofersen’s Impact on ALS Disease Progression, Survival
4
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
5